Drug Profile
Thiomarinol B
Latest Information Update: 27 Sep 1997
Price :
$50
*
At a glance
- Originator Sankyo
- Class Antibacterials
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections
Most Recent Events
- 18 Apr 1997 New profile
- 18 Apr 1997 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 18 Apr 1997 Preclinical development for Bacterial infections in Japan (Unknown route)